
(Updated - July 9, 2024 11:31 AM EDT)
Investing.com -- U.S. stock futures edged higher Tuesday following the start of two-day testimony from Fed chief Jerome Powell to Congress. Powell said the economy has made considerable progress toward the Federal Reserve's 2 percent inflation goal, and labor market conditions have cooled while remaining strong.
Here are some of the biggest U.S. stock movers today:
Intel (NASDAQ:INTC) stock fell 0.1% after gaining over 6% in the previous session, while Nvidia (NASDAQ:NVDA) rose 3% and Marvell (NASDAQ:MRVL) was down 1.2%, as stocks linked with AI were mixed.
Pfizer (NYSE:PFE) (PFE) stock fell 2% after it announced its chief scientific officer Mikael Dolsten would step down after a more than 15-year career at the drugmaker.
Eli Lilly (NYSE:LLY) stock rose 0.8% and Novo Nordisk (NYSE:NVO) stock fell 1.8% after the publication of a data analysis showing Eli Lilly's treatment Mounjaro leads to faster and greater weight loss than Novo’s popular obesity drug Wegovy.
Lucid Group (NASDAQ:LCID) stock fell 3% after the EV manufacturer will have to recall over 5,000 of its 2022-2023 Air luxury sedans due to a software error that could cause a loss of power.
BP (NYSE:BP) ADRs fell 4.1% after the energy giant warned that its second-quarter results will be hit by lower refining margins and it also expects to post an impairment of up to $2 billion.
Helen of Troy (HELE) stock slumped 30% after the consumer products company reported disappointing first-quarter results and slashed its full-year outlook, amid particular weakness in its beauty and wellness business.
UiPath Inc. (NYSE:PATH) fell 7% after it announced plans to cut around 10% of its global workforce.
ServiceNow (NYSE:NOW) declined 3.5%, extending yesterday's fall, after analysts downgraded the stock to "sell" due to concerns about risks to its business in the second half of the year.
Additional reporting by Louis Juricic
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.